Safety of Paxlovid Among Patients with Moderate or Severe Hepatic or Renal Impairment

First published 14/12/2022

Last updated 19/08/2024

EU PAS number:

EUPAS50123

Study

Ongoing

Documents

Study protocol

Initial protocol

C4671047_PROTOCOL_V1_16NOV2022

English (3.98 MB - PDF) View document

Updated protocol

C4671047_PROTOCOL AMENDMENT 2_V3_21JUN2023_SIGNED

First published: 22/02/2024

English (1.32 MB - PDF) View document

Study results

Study report

Other information

Study, other information

1047_DeclarationofInterests_combined.pdf

English (2.79 MB - PDF) View document

1047_DeclarationofInterests-Annex5_template _Muhammad Younus.pdf

English (104.35 KB - PDF) View document

Secondary tabs